Saturn V Capital Management LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$198.2B
Holdings
21
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 199,264 | $31.1B | 15.67% | |
| 2 | IRONDISC MEDICINE INC | 518,177 | $25.7B | 12.98% | |
| 3 | CGONCG ONCOLOGY INC | 577,696 | $14.1B | 7.14% | |
| 4 | XENEXENON PHARMACEUTICALS INC | 413,711 | $13.9B | 7.00% | |
| 5 | MRUSMERUS N V | 323,211 | $13.6B | 6.87% | |
| 6 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 343,849 | $13.4B | 6.78% | |
| 7 | SNDXSYNDAX PHARMACEUTICALS INC | 1,041,280 | $12.8B | 6.46% | |
| 8 | CELCCELCUITY INC | 1,093,677 | $11.1B | 5.58% | |
| 9 | COGTCOGENT BIOSCIENCES INC | 1,480,020 | $8.9B | 4.47% | |
| 10 | PCVXVAXCYTE INC | 232,295 | $8.8B | 4.43% | |
| 11 | AMLXAMYLYX PHARMACEUTICALS INC | 2,426,436 | $8.6B | 4.33% | |
| 12 | ARGXARGENX SE | 13,862 | $8.2B | 4.14% | |
| 13 | CNTACENTESSA PHARMACEUTICALS PLC | 448,692 | $6.5B | 3.26% | |
| 14 | OCULOCULAR THERAPEUTIX INC | 598,191 | $4.4B | 2.21% | |
| 15 | CTNMCONTINEUM THERAPEUTICS INC | 560,979 | $3.9B | 1.98% | |
| 16 | ABVXABIVAX SA | 552,926 | $3.5B | 1.74% | |
| 17 | KALVKALVISTA PHARMACEUTICALS INC | 255,060 | $2.9B | 1.49% | |
| 18 | NAMSNEWAMSTERDAM PHARMA COMPANY | 116,353 | $2.4B | 1.20% | |
| 19 | SLNSILENCE THERAPEUTICS PLC | 732,463 | $2.1B | 1.04% | |
| 20 | CRNXCRINETICS PHARMACEUTICALS IN | 59,017 | $2.0B | 1.00% | |
| 21 | INZYINOZYME PHARMA INC | 499,254 | $454.3M | 0.23% |